文献速递心力衰竭与心肌病心律失常高血压

芬兰人群中与心脏肥厚相关心源性猝死及心血管结局相关的遗传变异

Genetic variants associated with cardiac hypertrophy-related sudden cardiac death and cardiovascular outcomes in a Finnish population.
PubMed 文献 · Heart · 2024-12-23

研究对96例非缺血性心源性猝死且尸检提示高血压相关左心室肥厚及心肌纤维化的受试者行全外显子测序,筛选罕见有害变异,并在FinnGen数据集中验证其与心血管终点的关联。共发现18个可能影响蛋白功能的变异,其中14个与心肌病、心衰、传导异常、高血压和/或心脏骤停相关,3个被分类为致病或可能致病。

要点

  • 在高血压相关左心室肥厚的猝死患者中可检出罕见有害基因变异。
  • 多数检出的罕见变异在一般人群中与心衰、心肌病、心脏骤停和高血压相关。
  • 3个变异被分类为致病或可能致病,涉及RFX5、DHRS7C和VIL1基因。

核心结论

  • 在尸检提示高血压相关左心室肥厚及心肌纤维化的非缺血性心源性猝死受试者中检出了与左心室肥厚相关的罕见有害变异,其中多个变异在一般人群中与心衰、心肌病、心脏骤停和高血压等心血管终点相关。

研究设计与样本

  • 研究采用全外显子测序,纳入96例非缺血性心源性猝死且尸检提示高血压相关左心室肥厚及心肌纤维化的受试者,筛选次要等位基因频率<0.005且估计有害的罕见变异。
  • 将检出的变异与芬兰国家遗传研究FinnGen数据集中的心脏疾病终点进行关联验证。

主要发现

  • 共发现18个估计可能影响蛋白功能的变异,其中14个在FinnGen中与心肌病、心衰、传导异常、高血压和/或心脏骤停相关。
  • 3个变异被分类为致病或可能致病,包括调控因子X5的剪接位点变异NM_000449.3:c.234-1G>A,以及脱氢酶/还原酶7C的移码变异NM_000449.3:c.234-1G>A和vill in like的移码变异NM_015873.3:c.1164del。

临床怎么用

  • 对尸检提示高血压相关左心室肥厚及心肌纤维化的心源性猝死病例,可考虑罕见有害基因变异的检测与解读。
  • 检出的罕见变异在一般人群中与心衰、心肌病、心脏骤停和高血压相关,提示其可能具有心血管风险提示价值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hypertrophic cardiomyopathy is a common cause of non-ischaemic sudden cardiac death (SCD). Left ventricular hypertrophy (LVH) without cardiomyopathy-related myocardial disarray is a common autopsy finding and is often associated with prior hypertension in SCD subjects. Our aim was to investigate novel rare gene variants among SCD subjects with presumably hypertension-related LVH and myocardial fibrosis at autopsy. METHODS: Whole exome sequencing was used to study rare variants (minor allele frequency<0.005) estimated to be deleterious in 96 non-ischaemic SCD subjects with presumably hypertension-related LVH and myocardial fibrosis. Associations of the identified variants with cardiac disease endpoints were replicated in the Finnish national genetic study (FinnGen) dataset. RESULTS: 18 variants were estimated likely to affect protein function and 14 of these were associated with cardiomyopathies, heart failure, conduction abnormalities, hypertension and/or cardiac arrest in Finnish population (FinnGen). Three of the variants were classified as pathogenic or likely pathogenic. These include the splice site variant NM_000449.3:c.234-1G>A in regulatory factor X5 and frameshift variants NM_000449.3:c.234-1G>A in dehydrogenase/reductase 7C and NM_015873.3:c.1164del in villin like. CONCLUSIONS: We identified rare deleterious variants associated with LVH in SCD subjects. Several of the identified rare variants associated with cardiovascular endpoints including heart failure, cardiomyopathies, cardiac arrest and hypertension in general population.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Doedens A, Skarp S, Holmström L, et al. Genetic variants associated with cardiac hypertrophy-related sudden cardiac death and cardiovascular outcomes in a Finnish population. Heart. 2024. PMID: 39362746. doi:10.1136/heartjnl-2024-324623

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。